So, based on the experimental data and result, we proposed a hypothesis that NAC could rebalance the Th17/Treg ratio and improve the immune status of COPD patients through downregulating HIF1-a. The gene discussed is HIF1A; the disease is chronic obstructive pulmonary disease.